Search research articles
Contact Us
Filters
Showing results (131-140 of 163) with videos related to
Page
of 17
Sort By:
Neuroimage
|
November 13, 2020
Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain
Yasuharu Yamamoto, Keisuke Takahata, Manabu Kubota, et al.
The Lancet. Psychiatry
|
March 20, 2025
The trajectory of sedative adverse events caused by antipsychotics: a meta-analysis of individual participant data from randomised, placebo-controlled, clinical trials in acute phase schizophrenia
Nobuyuki Nomura, Spyridon Siafis, Johannes Schneider-Thoma, et al.
Schizophrenia Research
|
June 1, 2011
The evolution of antipsychotic switch and polypharmacy in natural practice--a longitudinal perspective
Chisa Tsutsumi, Hiroyuki Uchida, Takefumi Suzuki, et al.
Therapeutic Advances in Psychopharmacology
|
May 28, 2021
Comprehensive assessment of exposure to clozapine in association with side effects among patients with treatment-resistant schizophrenia: a population pharmacokinetic study
Nobuyuki Nomura, Kohei Kitagawa, Ryuhei So, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 21, 2019
Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study
Parita Shah, Yusuke Iwata, Eric E Brown, et al.
The Journal of ECT
|
August 28, 2009
Impacts of switching antidepressants after successful electroconvulsive therapy on the maintenance of clinical remission in patients with treatment-resistant depression: a chart review
Shinichiro Nakajima, Takuto Ishida, Rei Akaishi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 3, 2018
The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) data
Miracle Ozzoude, Shinichiro Nakajima, Eric Plitman, et al.
Schizophrenia Bulletin
|
February 11, 2017
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
Eric Plitman, Yusuke Iwata, Fernando Caravaggio, et al.
Journal of Alzheimer'S Disease : JAD
|
November 1, 2015
Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment
Jun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
Psychopharmacology
|
August 19, 2007
How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting
Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 163) with videos related to
Sort By:
Page
of 17
Neuroimage
|
November 13, 2020
Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain
Yasuharu Yamamoto, Keisuke Takahata, Manabu Kubota, et al.
The Lancet. Psychiatry
|
March 20, 2025
The trajectory of sedative adverse events caused by antipsychotics: a meta-analysis of individual participant data from randomised, placebo-controlled, clinical trials in acute phase schizophrenia
Nobuyuki Nomura, Spyridon Siafis, Johannes Schneider-Thoma, et al.
Schizophrenia Research
|
June 1, 2011
The evolution of antipsychotic switch and polypharmacy in natural practice--a longitudinal perspective
Chisa Tsutsumi, Hiroyuki Uchida, Takefumi Suzuki, et al.
Therapeutic Advances in Psychopharmacology
|
May 28, 2021
Comprehensive assessment of exposure to clozapine in association with side effects among patients with treatment-resistant schizophrenia: a population pharmacokinetic study
Nobuyuki Nomura, Kohei Kitagawa, Ryuhei So, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 21, 2019
Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study
Parita Shah, Yusuke Iwata, Eric E Brown, et al.
The Journal of ECT
|
August 28, 2009
Impacts of switching antidepressants after successful electroconvulsive therapy on the maintenance of clinical remission in patients with treatment-resistant depression: a chart review
Shinichiro Nakajima, Takuto Ishida, Rei Akaishi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 3, 2018
The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) data
Miracle Ozzoude, Shinichiro Nakajima, Eric Plitman, et al.
Schizophrenia Bulletin
|
February 11, 2017
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
Eric Plitman, Yusuke Iwata, Fernando Caravaggio, et al.
Journal of Alzheimer'S Disease : JAD
|
November 1, 2015
Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment
Jun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
Psychopharmacology
|
August 19, 2007
How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting
Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, et al.
Page
of 17